Watch The Hot Spots For Pharma Self-Regulation

Law360, New York (July 12, 2013, 1:06 PM EDT) -- As the global trend toward legislatively mandated transparency in the relationships between life sciences companies and health care professionals accelerates, the pharmaceutical industry is actively pursuing a different approach — self regulation. Supporters of transparency legislation argue that only governmentally imposed disclosure will reduce the cost of drugs and the prevalence of corruption.

Conversely, advocates of industry self-regulation emphasize that only their approach can lead to global uniformity and a much more manageable, understandable and cost-effective path to transparency. As the debate between supporters of government...
To view the full article, register now.